- A New Frontier for Convergence in Gastroenterology and Hepatology
Nov. 29(Fri) 11:00-12:30 |
H.pylori eradication: Current practices | Emerald Hall B (3F) |
Chair(s) | Dongho Lee (Korea), Jun Haeng Lee (Korea) | |
11:00-11:10 | Correlation between the result of antimicrobial susceptibility testing and outcome of eradication therapy for Helicobacter pylori | Young Min Kim (Korea) |
11:10-11:20 | Current trend in the Helicobacter pylori eradication rates of first-line sequential and concomitant therapies in Korea: A nationwide multicenter retrospective study over the 10 years | Bong Eun Lee (Korea) |
11:20-11:30 | Superior efficacy of gastric juice-guided first-line H pylori eradication, a prospective randomized controlled trial | Meng-Shu Hsieh (Taiwan) |
11:30-11:40 | Annual Eradication Rate of Bismuth-Containing Quadruple Therapy as Second-Line Treatment for Helicobacter pylori Infection : a Prospective study for 15 years in the tertiary hospital in Korea | Kichul Yoon (Korea) |
11:40-11:50 | Efficacy and Cost-effectiveness of Helicobacter pylori Eradication: Comparison of Tailored Therapy based on Clarithromycin Resistance and Concomitant Therapy | Kyungeun Lim (Korea) |
11:50-12:00 | Proton Pump Inhibitor Switching Strategy after the failure of Standard Triple Therapy for Helicobacter pylori Eradication. | Jaeyoung Kim (Korea) |
12:00-12:10 | Comparison between conventional quadruple therapy administered four times-a-day and a revised regimen administered twice-a-day for second-line Helicobacter pylori eradication | Ji Yeon Kim (Korea) |
12:10-12:25 | Wrap up lecture | In Kyung Sung (Korea) |
Nov. 29(Fri) 16:00-17:30 |
Topic Forum (PB1) | Emerald Hall B (3F) |
Chair(s) | Seon Mee Park (Korea), Seungmin Bang (Korea) | |
16:00-16:10 | Establishment of Patient Derived Pancreatic Ductal Adenocarcinoma Organoids platform and analysis of its Characteristics | Joo Hye Song (Korea) |
16:10-16:20 | Establishment of patient-derived pancreatic cancer organoid by means of EUS-FNA: Comparison between core biopsy tissues and organoids | Jee Hyung Lee (Korea) |
16:20-16:30 | Successful establishment of pancreatic cancer patient-derived orthotopic xenograft models | Jun Hyuk Kang (Korea) |
16:30-16:40 | Whole Exome Sequencing of Primary Pancreatic Ductal Adenocarcinoma and Paired Liver Metastasis | Tae-Se Kim (Korea) |
16:40-16:50 | Integrative analysis for genomic profiling of multifocal intrahepatic cholangiocarcinoma: Clinically relevant evidence for precision therapeutic strategies | Sung Hwan Lee (United States) |
16:50-17:00 | Single Cell Analysis of Primary and Metastatic Pancreatic Cancer Cells | Nam Joong Kim (Korea) |
17:00-17:10 | Analysis of Extracellular Vesicles (EVs) and Clinical Application in Pancreatic Cancer | Myung Ji Goh (Korea) |
17:10-17:25 | Topic forum | Joo Kyung Park (Korea) |